Brinks Attorney Jennifer Fox to Address Recent Biotech Patent Litigation at BIO IP & Diagnostics Symposium

Fox will present “Recent Patent Litigation and Disputes” with a panel of biotechnology and IP law professionals that will discuss the implications for the biotech industry of the decisions of the U.S. Supreme Court’s decisions in the Myriad and Prometheuscases, along with other recent decisions and ongoing cases.

Fox focuses her practice on counseling pharmaceutical and biotechnology companies in patent and related transactional matters. Both a research scientist and patent attorney, she has over 17 years of experience in the pharmaceutical and biotechnology industries. She is Of Counsel in Brinks’ office in Research Triangle Park, N.C.

BIO IPDX will review the current patent law landscape and evaluate its impact on both the genetic diagnostics and biopharmaceutical sectors. The program will explore IP issues for both general and companion diagnostics, as well as potential regulatory dimensions. The symposium is geared towards patent practitioners in the life sciences, both in-house and in private practice, as well as in-house regulatory affairs staff, licensing professionals, business development executives, and regulatory agency staff seeking to understand pre-marketing and intellectual property challenges in the area of diagnostics.

Although there is no fee to attend, reservations are required. For more information and to register, contact Caroline Arrington at carrington@bio.org or (202) 962–9228.

Brinks Gilson & Lione